Resistance to beta-lactams and glycopeptides in staphylococci and streptococci.
Molecular mechanisms of the action of beta-lactam and glycopeptide antibiotics, as well as genetic background and phenotypical features of the resistance of staphylococci, streptococci and enterococci to these antibiotics are reviewed. Furthermore, susceptibility patterns concerning beta-lactam and glycopeptide drugs of staphylococcal, streptococcal, as well as enterococcal strains isolated from clinical specimens at the Semmelweis University of Medicine, Budapest, Hungary between January 1997 and December 2000 are also presented.
Rozgonyi
F
F
Institute of Medical Microbiology, Faculty of General Medicine, Semmelweis University, P.O. Box 370, H-1445 Budapest, Hungary.
Ostorházi
E
E
Maródi
C L
CL
Ghidán
A
A
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D024881:Drug Resistance, Bacterial / Q000235:genetics / Q000502:physiology; D016983:Enterococcus / Q000187:drug effects / Q000235:genetics; D006020:Glycopeptides; D010641:Phenotype; D013210:Staphylococcus / Q000187:drug effects* / Q000201:enzymology / Q000235:genetics; D013291:Streptococcus / Q000187:drug effects* / Q000201:enzymology / Q000235:genetics; D001618:beta-Lactamases / Q000235:genetics; D047090:beta-Lactams
D000900:Anti-Bacterial Agents; D006020:Glycopeptides; D047090:beta-Lactams; D001618:beta-Lactamases